Guardian Pharmacy Services, Inc.
GRDN
$38.87
$1.784.80%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.31% | 13.54% | 17.93% | 18.68% | 18.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.31% | 13.54% | 17.93% | 18.68% | 18.53% |
| Cost of Revenue | 7.57% | 11.92% | 17.47% | 18.77% | 18.97% |
| Gross Profit | 21.54% | 20.13% | 19.78% | 18.32% | 16.72% |
| SG&A Expenses | -28.14% | -30.05% | -30.02% | -20.24% | 98.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.71% | 2.18% | 6.25% | 10.09% | 31.16% |
| Operating Income | 239.40% | 252.25% | 232.38% | 262.59% | -200.23% |
| Income Before Tax | 250.35% | 236.29% | 210.45% | 185.92% | -308.89% |
| Income Tax Expenses | 141.11% | 202.55% | 436.98% | 10,701.70% | -- |
| Earnings from Continuing Operations | 187.67% | 180.57% | 168.92% | 157.87% | -348.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 90.30% | 98.62% | 101.61% | 103.73% | 61.25% |
| Net Income | 180.16% | 168.17% | 156.39% | 146.14% | -681.55% |
| EBIT | 239.40% | 252.25% | 232.38% | 262.59% | -200.23% |
| EBITDA | 369.51% | 398.05% | 352.53% | 565.45% | -150.38% |
| EPS Basic | 160.73% | 151.30% | 143.75% | 117.35% | -883.72% |
| Normalized Basic EPS | 224.97% | 208.34% | 185.14% | 155.72% | -962.46% |
| EPS Diluted | 160.06% | 150.72% | 143.22% | 116.86% | -885.86% |
| Normalized Diluted EPS | 222.86% | 206.74% | 183.96% | 154.83% | -969.69% |
| Average Basic Shares Outstanding | 1.95% | 1.80% | 35.37% | 103.01% | 304.42% |
| Average Diluted Shares Outstanding | 1.84% | 2.43% | 36.84% | 106.30% | 308.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -1.05% |